VIENNA – Nonalcoholic fatty liver disease (NAFLD) now stands as the second most common cause of U.S. cases of hepatocellular carcinoma, and with hig... More »
VIENNA – Roughly half of American adults with chronic hepatitis C infection are unaware of their infection, and about one-fifth of these people with... More »
VIENNA – A new, once-daily, single-pill regimen for treating chronic hepatitis C infection without interferon or ribavirin showed 95% eradication ef... More »
As health officials continue to battle an intravenous drug use–related HIV outbreak in a rural county in Indiana, the Centers for Disease Control an... More »
Neither pentoxifylline nor prednisolone reduced 28-day mortality, 90-day mortality, or 1-year mortality among adults with alcoholic hepatitis in a mul... More »
The Food and Drug Administration has approved changes to the warnings and precautions section of the package insert for Olysio (simeprevir).
One addi... More »
Insulin glargine therapy was associated with significantly greater reductions in liver fat burden in patients with type 2 diabetes than was liraglutid... More »
The high cost of the hepatitis C treatment Sovaldi has caused a steep increase in Medicaid spending, though access to the drug remains extremely limit... More »
Three-quarters of Crohn’s fistula patients who were treated with one or two doses of autologous mesenchymal stem cells derived from adipose tissue a... More »
Repurposing the antihistamine medication chlorcyclizine may be a viable option in the treatment of hepatitis C, reported Dr. Shanshan He and coauthors... More »
